Aluminum-Based Metal−Organic Framework Nanoplatform Combines Chemo-Nanotherapy in an Intrahepatic Walker 256 Rat Tumor Model: Association with Glycerophospholipid Metabolic Changes
Hepatocellular carcinoma (HCC) treatment is severely limited by the low efficacy and drug resistance of current monotherapies. While nanocarriers for sorafenib (Sor) delivery have been explored, platforms that combine multimodal therapy and elucidate deep-seated anti-tumor mechanisms remain lacking. To address this,...